Abstract
Results:
sAGEs ( Ncarboxymethyllysine, methylglyoxal) were markedly elevated in obese persons with more than one other MS criteria but not in obese without MS criteria. sAGEs directly correlated with markers of IR (HOMA) and inflammation (leptin, TNFα, RAGE) and inversely with innate defenses (SIRT1, AGE receptor 1 [AGER1], glyoxalaseI, adiponectin). sAGEs correlated with dAGEs but not with calories, nutrient consumption, or fat mass measures. Consumption of dAGE, but not of calories, was markedly higher in MS than in nonMS.
Conclusion:
High sAGEs, a modifiable risk factor for IR, may indicate risk for the MS, type 2 diabetes, and cardiovascular disease. High dietary AGE consumption and serum AGE levels may link healthy obesity to atrisk obesity.
The Metabolic Syndrome (MS) was first described as a group of risk factors for type 2 diabetes (T2D) and cardiovascular disease (CVD). The factors include insulin resistance (IR), obesity, hypertension, and dyslipidemia (1,-3) . These conditions are each associated with chronic oxidant stress and inflammation (OS/Inflam) (3), the cause of which remains poorly understood. The general consensus is that there is a continuum between risk for the MS features and progression to overt T2D or CVD. Obesity is a most challenging condition, in part due to the difficulty of cost effectively identifying and treating those obese who are at risk for developing T2D and CVD (4, 5) .
Advanced glycation endproducts (AGEs) or glycotoxins are a group of prooxidant, cytotoxic compounds that contribute to chronic inflammation and diabetic complications (6,-8) . Although hyperglycemia is traditionally thought to be the major source of AGEs, they can also be diet derived and causally involved in IR and T2D (6) . AGEs are present in many animal food products, particularly those processed under high heat, as is often the case with Western diets (6, 9,-12) .
A close association has been reported between the AGEs present in the diet (dAGE) and the amounts of food or calories consumed (13) . Because the absolute quantities of both AGEs and calories consumed can drive obesity, it has been difficult to sort out the contribution of each of these risk factors. Chronic exposure to a diet with a high content in dAGEs promotes chronic inflammation and IR (6, 13) . A direct correlation has been reported between circulating proteinassociated AGE markers, such as N carboxymethyllysine (CML) or methylglyoxal derivatives, such as MGH1, proinflammatory factors, and IR in healthy adults (13, 14) . High levels of these serum AGE (sAGE) markers were also strongly linked to suppressed levels of innate defense factors, such as sirtuin 1 (SIRT1), a major deacetylase with antiinflammatory and metabolic functions (15) and AGE receptor 1 (AGER1), an AGE receptor with anti oxidant stress (OS) properties (16) . Adult mice, which were exposed for life to an MGsupplemented diet developed visceral adiposity and IR, coupled with an imbalance in innate defense response and inflammation, all absent in agematched mice fed a lowAGE diet (17, 18) . Clinical studies further suggested that the standard AGEreplete diet may be linked to a higher body mass index (BMI), IR, and T2D (10, 17,-22) . Other studies in mice have proposed a role for receptors that bind AGEs and promote OS, such as RAGE and Tolllike receptor2 in adipocyte hypertrophy, indirectly implicating AGEs in obesity and IR (18, 22) . However, an inverse association between levels of sAGEs and IR, BMI, or fat mass has also been reported (23, 24) ; hence, there is a clear need for further studies.
The current crosssectional study was undertaken in subjects with and without MS criteria to assess the association between established markers of endogenous and exogenous AGEs and their interaction with MS features. The results suggest that serum AGEs, in tandem with inflammatory markers, are elevated in obese persons with one or more features of the MS but not in obese persons without MS criteria. Beyond overnutrition, a high dAGE consumption may link healthy obesity to atrisk obesity.
Materials and Methods

ϵ ϵ
Participants underwent a physical examination and provided their medical history, fasting blood, and a 24 hour urine sample. Patients with the MS also underwent abdominal magnetic resonance imaging (MRI) studies to define the subcutaneous (SAT) and visceral adipose tissue (VAT) distribution (26) (Supplemental Information). Routine blood tests were performed in the hospital clinical laboratory. Renal function was estimated from the clearance of endogenous creatinine: creatinine clearance (milliliters per minute) = (urine volume in milliliters per minute × urine creatinine concentration in milligrams per deciliter)/serum creatinine concentration in milligrams per deciliter.
Dietary intake
Assessment of daily dietary AGE content was based on 3day food records that emphasized cooking methods and was estimated from a database of approximately 560 foods that lists AGE values (9) and was expressed as AGE equivalents (Eq) per day (1 AGE equivalent = 1000 kilounits). The 3day food record was defined as the estimated amount of food and beverages consumed at home or away from home, based on established guidelines developed to assist in estimating portions. Nutrient intakes were estimated from food records using a nutrient software program (Food Processor version 10.1; ESHA Research).
AGE determination
AGEs in serum, urine, and peripheral mononuclear cell (PMNC) lysates were determined by well validated competitive ELISAs based on noncrossreactive monoclonal antibodies (mabs) for protein bound CML (4G9 mab) and proteinbound MG derivatives, ie, hydroimidazolone MGH1 (3D11 mab), characterized by HPLC, and used as immunogens (27, 28) . The resulting values thus reflect relatively stable protein or peptideassociated CML and MG and not the free compounds.
Statistical analysis
Abdominal obesity was defined as a waist circumference of 102 cm or greater in men and 88 cm or greater in women. Data are reported as means ± SEM for continuous variables and as percentages of total for categorical variables, unless otherwise specified. The KolmogorovSmirnov goodnessoffit test was used to test for normal distributions. Variables not normally distributed were logarithmically transformed before hypothesis testing. Comparison between the means was made using a Student's t test or an ANOVA, depending on the number of groups. Associations between variables were explored using simple linear 1c regression and Spearman correlation coefficients. Tests were considered significant if the twosided value was P < .05. Analyses were carried out using SPSS version 20.
Further methodological details are provided as Supplemental Information.
Results
General description of the population
The MS cohort included participants with two or more MS features. Subjects with MS had higher weight, WC, BMI, percentage body fat, diastolic BP, and mean levels of fasting blood glucose, homeostasis model assessment index (HOMA) and triglycerides but lower HDLcholesterol than nonMS subjects (Table 1) . Estimated renal function in both MS and nonMS subjects was within normal limits, and there was no proteinuria (Table 1) . However, the mean 24hour urinary excretion of both CML and MG was higher (by >2fold) in MS than in nonMS subjects ( Table 1) .
Diet and AGEs
The consumption of calories, nutrients and dAGEs was significantly higher in MS than in nonMS subjects ( Table 1 and Supplemental Table 1 ). However, the consumption of dAGEs by MS subjects was disproportionally greater than that of calories (46% vs 15%), compared with nonMS subjects (Table 1 and Figure 1A ), including those with obesity ( Table 2 ). The dietary AGE intake in MS subjects remained significantly higher, even when expressing dietary AGE per amount of calories ingested (Table 1) . Total dAGEs, as well as dietary protein and fatassociated AGEs, closely correlated with the intake of calories, protein, fat, saturated fat, and, to a lesser degree, carbohydrates (Supplemental Table 2 ). Dietary AGE intake also correlated with serum (s) CML and sMG in both cohorts (Table 3) .
Mean levels of two AGEs in serum (sAGEs) and PMNCs [intracellular AGEs (iAGE)], intracellular CML (iCML) and intracellular MG (iMG), plasma 8isoprostanes, and leptin were markedly elevated in MS compared with nonMS subjects (Table 1) . A strongly positive correlation was found between sCML and sMG in both MS and nonMS subjects. However, the intersection points of each slope differed, in that for any given level of sCML, the corresponding level of sMG was higher in MS subjects relative to nonMS subjects ( Figure 1B ). There was also a positive correlation between serum and intracellular CML and serum and intracellular MG in MS subjects ( Figure 1 , b1 and b2).
Body mass and AGEs
Although there were positive intraindividual and group correlations between WC, BMI, and percentage body fat mass (by bioimpedance), there was no overall correlation between these body mass markers and sAGEs in either the MS or nonMS groups ( Figure 1C ). Also, there was no correlation between sAGEs and percentage SAT or VAT mass in MS subjects, as defined by MRI (Table 3) .
When MS subjects were stratified by number of MS criteria present, the mean levels of sAGEs were markedly and equally increased in obese MS subjects with one or more criteria ( Figure 1D ). Mean PMNC levels of TNFα were also twice as high in obese subjects with one or more MS criteria ( Figure 1E ).
Because WC is an important predictor of the MS, we compared data from MS subjects, most of whom had at least a high WC, with nonMS subjects with a high WC (Table 2) . sAGEs, iAGEs, urinary AGEs, markers of inflammation, as well metabolic indices were distinctly elevated in the MS group but not in nonMS subjects despite a high WC (Table 2) . Similar results were obtained for other body mass indices, eg, BMI or percentage body fat.
Inflammation, innate defenses, and AGEs
PMNC levels of proinflammatory RAGE and TNFα were higher in MS than in nonMS subjects, whereas the levels of the antiinflammatory SIRT1 were decreased (Table 1) . Mean PMNC mRNA levels of glyoxalaseI were also decreased in MS, compared with nonMS subjects (Table 1) . MS subjects had lower fasting blood glucose, fasting plasma insulin, HbA , HOMA, leptin, and PMNC TNFα than those reported in diabetic patients (21) .
Strongly positive correlations were found between sAGEs (CML and MG) and markers of OS/Inflam (8 isoprostanes, leptin, PMNC TNFα protein, and RAGE mRNA) in MS subjects and nonMS subjects (  Table 3 ). When the relationships of sAGEs with metabolic or inflammatory factors, namely HOMA, leptin, 8isoprostanes, and TNFα were examined together, the trajectories of each parameter, although positive in both cohorts, were distinct for MS and nonMS groups, indicating a substantially higher level of sCML and sMG as well as OS/Inflam and IR markers in the MS than in the nonMS groups (Figure 2, A-D) . By comparison, significant negative correlations were noted in the MS cohort between levels of sAGEs (sCML and sMG) and levels of innate defenses (SIRT1, AGER1, adiponectin, and glyoxalase) (Figure 2 , E and F, and Table 3 ). Similar trends were observed in nonMS subjects, except for AGER1 mRNA that correlated positively with sAGEs in this cohort (Table 3 ) (6, 29) .
Sex, race, ethnicity, and AGEs
Men with MS displayed higher BMI, percentage body fat, and VAT (by MRI) than women with MS, but a similar WC (Table 4 ). Men had a higher caloric intake (20% greater than women) and dAGE consumption (42% greater than women). No significant sex differences were found in the levels of sAGEs, pro or anti OS/Inflam markers, metabolic or renal function parameters (except for a higher HDL and urinary AGE excretion in women) ( Table 4) .
Of the 130 MS participants, 40% were African American, 37% Caucasian, 4% Asian, and 18% of mixed or undetermined race. Twentyone percent considered themselves as Hispanics. We observed no significant racial or ethnic differences in any parameters assessed.
Discussion
We report that subjects with MS display markedly elevated serum levels of two distinct markers of protein bound AGEs, sCML and sMG, both of which strongly correlate with markers of inflammation and impaired metabolism. Although overall sAGEs were not associated with markers of fat mass, in the presence of obesity and one or more MS criteria, sAGE levels were markedly higher, as was dietary AGE consumption. Thus, high sAGE levels in obese adults could serve as a signal of an impending transition from benign obesity to the MS. Given that sAGEs are a modifiable, nontraditional risk factor, these findings may aid in the timely and targeted prevention of the risk for MS, if confirmed in prospective or interventional studies.
Because the MS subjects in this study did not have unbalanced diabetes (HbA levels < 6.5%), hyperglycemia could be ruled out as the cause of the excessive sAGEs (13, 19, 20, 30) . Although sAGEs were strongly associated with HOMA and leptin levels, two indicators of IR tied to obesity, they did not directly correlate with measures of body fat, WC, BMI, and total and percentage fat mass by impedance or with VAT and SAT by MRI. An obvious source for the surplus sAGEs was the diet because the levels of AGEs in serum strongly correlated with those of the same AGE markers in the diet of both cohorts, even after adjusting for nutrient consumption (13, 14) . Because circulating AGEs have further been identified as a modifiable factor causally linked to chronic OS/Inflam and IR, which underlie the MS (23), the current evidence implicates high sAGEs as a risk factor for the MS.
Both caloric and dAGE consumption were higher in subjects with MS, consistent with their higher fat mass compared with nonMS. Although it is possible that increased energy intake, such as fat, can promote OS and endogenous AGE levels, the amount of dAGEs consumed by MS subjects was considerably ,-12, 30) . Habitual preference of such foods in excess can result in a modest elevation of sAGEs and inflammation, even without frank obesity (14, 19, 30) . Exogenously driven elevated sAGEs could thus act as initiators of cellular OS/Inflam, secondarily leading to newly formed cellderived iAGEs. This conclusion is supported herein by the strong correlations found between sAGEs and iAGEs, TNFα, and RAGE in PMNCs, used here as surrogates of tissue cells (14, 29, 31) . sAGEs and markers of OS/Inflam were not elevated in obese subjects who did not have other MS features, often referred to as metabolically healthy (1, 2, 4, 5) , consistent with the view that increased body fat is not necessarily indicative of risk for the MS. AGE levels were, however, strikingly elevated in obese MS subjects, even with only one more MS feature, a group not traditionally included in the MS (1, 2, 32) . The same subjects also displayed the highest titers of TNFα, consistent with evidence that high levels of AGEs promote inflammation and IR, thus risk of T2D or CVD (1,-6 ). In this context, superphysiological levels of sAGEs in otherwise healthy obese subjects could signal transition to other components of the MS cluster, such as high BP, dyslipidemia, or subclinical CVD and define early risk for MS. Furthermore, beyond overnutrition, a history of exposure to AGEenriched foods may reveal an important clue and a temporal link between healthy and unhealthy or MSprone obesity (4,-6).
The current clinical findings mirror those from studies in mice, which had been exposed for life to increased levels of specific dietary AGEs (MG). These mice developed visceral adiposity, IR, and altered innate immunity and metabolism (28) . Similarly, in the current study, high sAGE levels in the MS cohort negatively tracked with protective factors, such as SIRT1, an important regulator of insulin action and fat mobilization (15, 33) , antiinflammatory adiponectin (34), AGER1, a receptor that opposes AGEs and OS and RAGE overexpression (35) as well as glyoxalaseI, a key MGdegrading enzyme (36) . Functional depletion of these genes may further augment MSPMNC iAGEs, TNFα, and RAGE (21, 28, 31) . Similar, albeit weaker, correlations were also evident in nonMS subjects, arguing in favor of a dynamic continuum between healthy and unhealthy obese, who are prone to the MS (14) .
The changes in gene expression found in the PMNCs of MS subjects in this study were indicative of a proinflammatory macrophage (M1like) phenotype, similar to that observed in T2D subjects (21, 29, 38) . However, the absence of hyperglycemia represents an important difference between subjects with T2D and the current subjects with MS. AGEs could indeed serve as stimuli for the observed changes in PMNCs, and these, in turn, could modify the metabolic response of adipocytes (18, 28) . These findings offer strong support to the postulate that circulating immune cells, like macrophages, are active participants in tissue changes (28, 37, 38) and that these changes could be elicited as a result of persistent excess of sAGEs (29) .
Multiple traits can promote the MS, including race, ethnicity, and genetic variants (39). Because a major difference between the MS and nonMS cohorts was the amount of dAGEs consumed, the expression of each of these traits and role in the MS could be augmented in a setting of high external AGEs. This concept deserves attention, in light of evidence, which reveals a difference between overconsumption of nutrients and that of dAGEs. Because dAGE consumption is a determinant of sAGEs and their downstream effects, it may represent a dietbased risk factor that is distinct from overnutrition but evidently modifiable (6).
We found no sex differences with respect to sAGEs, iAGEs, or markers of pro and antiOS/inflam, HbA , IR, and lipid levels, except for HDL. This could be partially due to the small study size and overrepresentation of women.
The current study differs in several aspects from other reports, including selection criteria, age, sex, assessment of AGEs, the use of studyspecific selection criteria, and MRI for fat tissue distribution (24, 25) . In addition, unlike other studies, dAGEs, calories, and nutrient intakes were assessed based on a large AGE database and validated dietary tools, which we developed (6, 9, 14, 23) . Our findings fail to confirm an inverse relationship between body weight and sAGE levels (23, 24) . We, however, found that sAGE levels in healthy obese subjects who did not have the MS were lower than in obese subjects with more than one MS criteria. Thus, classification of the MS could also explain some of the data disparity. The current study relies on the immunoreactivity of two distinct proteinAGEs, the levels of which are found internally consistent with their welldefined biological properties across cellular, animal, and human studies (14, 19, 27, 28, 30, 31) . In conclusion, high levels of circulating AGEs in MS may reflect the net result of several dynamic processes: high and sustained dAGE intake, increased endogenous or iAGE production, and decreased tissue AGE catabolism. Longterm exposure to dAGEs may be crucial in the chronic inflammation that underlies risk for the MS and thus T2D or CVD, a concept that deserves further testing in interventional trials. Circulating AGEs may be a useful biomarker for the early detection of obese persons at risk for the MS as well as a means to monitor the efficacy of interventions. 
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Figure 2.
Fasting sMG levels plotted against markers of insulin resistance, inflammation, and OS in MS (solid lines) and nonMS subjects (dashed lines) (A-D) and against markers of innate defense mechanisms (E and F). A, sMG vs HOMA (MS: r = 0.464, P < .001; nonMS: r = 0.230; P < .001). B, sMG vs plasma leptin (MS: r = 0.677; P < .001; nonMS: r = 0.262; P = .018). C, 8Plasma isoprostanes (MS, r = 0.784; P < .001; nonMS, r = 0.594; P < .001). D, PMNC TNFα protein (MS, r = 0.654; P < .001; nonMS, r = 0.489; P < .001). E, sMG vs AGER1 mRNA (MS, r = −0.508; P = .002; nonMS, r = 0.336; P < .001). F, sMG vs SIRT1 mRNA (MS, r = −0.619; P < .001; nonMS, r = −0.255; P = .002). Abbreviations: HOMAIR, homeostasis model assessment index of insulin resistance; NA, not assessed; uMicroalbumin/creatinine, urinary microalbumin/urinary creatinine (milligrams per day); uProtein/creatinine, urinary protein/urinary creatinine (milligrams per day); Data are shown as mean ± SEM. A gender × MS interaction was tested and found nonstatistically significant except for the following: weight (P = .004), BMI (P = .004), waist (P = .001), dietary calories (P = .012), dietary AGEs (P = .001), and urinary protein/creatinine (P = .002).
Statistical difference between genders in nonMS cohort. Statistical difference between genders in MS cohort. 
